KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Cash from Financing Activities (2016 - 2026)

West Pharmaceutical Services has reported Cash from Financing Activities over the past 18 years, most recently at -$308.7 million for Q1 2026.

  • Quarterly Cash from Financing Activities fell 110.0% to -$308.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$346.8 million through Mar 2026, up 30.45% year-over-year, with the annual reading at -$185.1 million for FY2025, 70.27% up from the prior year.
  • Cash from Financing Activities was -$308.7 million for Q1 2026 at West Pharmaceutical Services, down from -$11.7 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at -$9.5 million in Q4 2022 and troughed at -$308.7 million in Q1 2026.
  • The 5-year median for Cash from Financing Activities is -$71.0 million (2023), against an average of -$110.0 million.
  • Biggest five-year swings in Cash from Financing Activities: crashed 12166.67% in 2022 and later skyrocketed 93.17% in 2025.
  • Tracing WST's Cash from Financing Activities over 5 years: stood at -$9.5 million in 2022, then crashed by 1894.74% to -$189.5 million in 2023, then surged by 63.64% to -$68.9 million in 2024, then skyrocketed by 83.02% to -$11.7 million in 2025, then plummeted by 2538.46% to -$308.7 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$308.7 million, -$11.7 million, and -$11.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.